ARI BOUSBIB
CIK 1184180 · See Remarks · last filed 2026-07-31
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$591.10M
Companies
6
Total Filings
90
Lifetime Open-Market Net
-$304.15M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IQV | See Remarks | 1,482,361 | $232.43 | $344.55M | -$236.10M | 39 | 2026-07-31 |
| HD | Director | 10,000 | $349.52 | $3.50M | $266.4K | 20 | 2026-05-26 |
| Q | See Remarks | 1,580,141 | $133.37 | $210.74M | -$22.09M | 6 | 2017-11-03 |
| IMS Health Holdings, Inc. (IMS) Delisted | See Remarks | 1,917,133 | — | — | $0 | 5 | 2016-10-03 |
| RTX | Pres., Commercial & UTC EVP | 144,755 | $223.25 | $32.32M | -$46.22M | 15 | 2010-03-26 |
| BBY | Director | — | $80.02 | — | $0 | 1 | 2007-04-12 |
Recent Filings · Page 3 of 9
90 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-09 | IQV | Mixed | +43,445 | -$10.38M | EDGAR |
| 2022-05-23 | HD | Grant (A) | — | $0 | EDGAR |
| 2022-02-14 | IQV | Grant (A) | +20,542 | $0 | EDGAR |
| 2022-02-11 | IQV | Mixed | +41,103 | -$12.79M | EDGAR |
| 2021-05-24 | HD | Grant (A) | — | $0 | EDGAR |
| 2021-02-11 | IQV | Mixed | +61,582 | -$6.62M | EDGAR |
| 2021-02-04 | IQV | Tax (F) | −61,522 | -$11.35M | EDGAR |
| 2020-10-14 | IQV | Mixed | — | -$11.17M | EDGAR |
| 2020-09-17 | IQV | Mixed | — | -$7.19M | EDGAR |
| 2020-08-18 | IQV | Mixed | — | -$10.60M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.